Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2008
12/25/2008US20080318237 Methods of diagnosing endometriosis
12/25/2008US20080318236 Cell Free Screening Assay and Methods of Use
12/25/2008US20080318235 Chromosomal Analysis By Molecular Karyotyping
12/25/2008US20080318234 Compositions and methods for diagnosing and treating cancer
12/25/2008US20080318233 Source tagging and normalization of DNA for parallel DNA sequencing, and direct measurement of mutation rates using the same
12/25/2008US20080318232 Nucleic Acid Biosensor with Photoelectrochemical Amplification
12/25/2008US20080318231 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type
12/25/2008US20080318230 Gene expression markers for response to egfr inhibitor drugs
12/25/2008US20080318229 Method for Diagnosing Neuro-Degenerative Disease
12/25/2008US20080318228 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
12/25/2008US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
12/25/2008US20080318226 Signal Amplification Method
12/25/2008US20080318225 Compositions and methods for detecting cancer
12/25/2008US20080318224 Large deletions in human brca1 gene and use thereof
12/25/2008US20080318223 Large deletions in human brca1 gene and use thereof
12/25/2008US20080318222 Cell Based Methods And Systems For The Identification Of Rna Regulatory Sequences And Compounds That Modulate Their Functions
12/25/2008US20080318221 Method for the diagnosis and/or prognosis of alzheimer's disease
12/25/2008US20080318220 Method for the diagnosis and/or prognosis of alzheimer's disease
12/25/2008US20080318219 Methods and compositions for predicting drug responses
12/25/2008US20080318218 Compositions and Methods for Inferring an Adverse Effect in Response to a Drug Treatment
12/25/2008US20080318217 Identification of Gene Associated with Reading Disability and Uses Therefor
12/25/2008US20080318216 Methods For Determining Presence of Cancer by Analyzing the Expression of Cdk9 and/or Cyclin T1 in Lymphoid Tissue
12/25/2008US20080318215 Apparatus, methods and products for detecting genetic mutation
12/25/2008US20080318214 Genome Analysis Method
12/25/2008US20080318213 Mass Spectrometer
12/25/2008US20080318212 Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer
12/25/2008US20080318211 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
12/25/2008US20080318210 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
12/25/2008US20080318209 Cjd Prion Testing
12/25/2008US20080318208 Dengue Reporter Virus and Methods of Making and Using the Same
12/25/2008US20080318207 Sequence covariance networks, methods and uses therefor
12/25/2008US20080318206 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
12/25/2008US20080318205 Hiv Type and Subtype Detection
12/25/2008US20080318204 Highly-Sensitive Genomic Assays Employing Chimeric Bacteriophage Standards
12/25/2008US20080318203 Novel Microfluidic System and Method for Capturing Cells
12/25/2008US20080317835 Personalized Nutrient Deficiency Assay Methods
12/25/2008US20080317811 Treatment of Cancer Using Tlr3 Agonists
12/25/2008US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection
12/25/2008US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins
12/25/2008US20080317756 Antibodies to Chemokine Alpha-5
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317753 Selecting patients for therapy with a her inhibitor
12/25/2008US20080317749 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
12/25/2008US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
12/25/2008US20080317745 Methods of diagnosing, treating, or preventing plasma cell disorders
12/25/2008US20080317742 Biomarkers of francisella infection
12/25/2008US20080317741 Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury
12/25/2008US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction
12/25/2008US20080317738 Mylks as Modifiers of Branching Morphogenesis and Methods of Use
12/25/2008US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor
12/25/2008US20080317733 Cosmeceutical Compositions and Methods with Biologically Active Ingredients
12/25/2008US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them
12/25/2008US20080317722 Methods and Compositions Involving Developmental Decision Promoter Regions
12/25/2008US20080317715 Anti-bacterial agents
12/25/2008US20080317674 Method and Reagent for Measuring Nitroreductase Enzyme Activity
12/25/2008US20080314882 Method of making a biosensor
12/24/2008WO2008157834A1 Materials and methods for diagnosis of asthma
12/24/2008WO2008157696A2 High throughput nucleic acid sequencing by expansion
12/24/2008WO2008157689A2 Methods of nucleic acid amplification analysis
12/24/2008WO2008157649A1 Non-enzymatic detection of bacterial genomic dna
12/24/2008WO2008157501A1 Salivary exon core transcriptome
12/24/2008WO2008157493A2 Use of zno nanocrystals for imaging and therapy
12/24/2008WO2008157437A1 Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer
12/24/2008WO2008157432A1 Polynucleotides and methods for making plants resistant to fungal pathogens
12/24/2008WO2008157384A2 Method of detection of microorganisms with enhanced bacteriophage amplification
12/24/2008WO2008157374A1 High-affinity monoclonal antibodies for botulinum toxin type a
12/24/2008WO2008157358A1 Methods for treating neoplasia and for identifying compositions useful in such therapy
12/24/2008WO2008157353A1 Methods of diagnosing and treating cancer
12/24/2008WO2008157277A1 Methods for evaluating breast cancer prognosis
12/24/2008WO2008157264A2 Combined methods for the detection of chromosomal aneuploidy
12/24/2008WO2008157230A1 Rsk inhibitors as anti-angiogenic therapeutics
12/24/2008WO2008156987A2 Riboswitches and methods and compositions for use of and with riboswitches
12/24/2008WO2008156867A1 Biomarkers for the diagnosis of autoimmune disease
12/24/2008WO2008156858A2 Use of pre-mrna splicing in platelet cells for the diagnosis of disease
12/24/2008WO2008156827A2 Molecular grading methods for ductal carcinoma in situ
12/24/2008WO2008156668A1 Transgenic mammals that produce exogenous proteins in milk
12/24/2008WO2008156650A2 Device, kit and method for hookworm antigen capture and detection
12/24/2008WO2008156605A1 Selection of useful fungal strains
12/24/2008WO2008156591A1 Prediction of schizophrenia risk using homozygous genetic markers
12/24/2008WO2008156582A1 Isotopically labeled compositions and method
12/24/2008WO2008156536A1 Methods for determining cytosine methylation in dna and uses thereof
12/24/2008WO2008156471A1 Non-invasive rapid diagnostic test for m. tuberculosis infection
12/24/2008WO2008156135A1 Method of measuring microparticles having nucleic acid and apparatus therefor
12/24/2008WO2008156069A1 Screening method for antibody and antibody obtained by the method
12/24/2008WO2008156048A1 Set of yeast cells, method of identifying target candidate molecule, method of analyzing action mechanism and screening method
12/24/2008WO2008155924A1 Glucose dehydrogenase
12/24/2008WO2008155742A2 Peptide nucleic acid (pna) probe, kit and procedure for specific detection of helicobacter pylori and applications thereof
12/24/2008WO2008155692A2 Molecular conformation biosensing
12/24/2008WO2008155599A1 Nested multiplex amplification method for identification of multiple biological entities
12/24/2008WO2008155549A2 Improved urine sample collecting and processing
12/24/2008WO2008155539A1 Electrochemical data rejection methodology
12/24/2008WO2008155531A1 Redox mediators
12/24/2008WO2008155529A1 Compositions
12/24/2008WO2008155524A1 Freeze-dried compositions for carrying out pcr and other biochemical reactions
12/24/2008WO2008135639A3 Novel useful inhibitors
12/24/2008WO2008134596A3 Use of methylated or unmethylated line-i dna as a cancer marker
12/24/2008WO2008134464A3 Sample-processing reagent compositions, methods, and devices
12/24/2008WO2008134461A3 Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
12/24/2008WO2008132687A3 Method for diagnosing susceptibility to post-traumatic scar-tissue formation
12/24/2008WO2008131367A3 Methods of diagnosing alzheimer's disease and markers identified by set association